Gain Therapeutics Inc (GANX) — Long-term Investment Intensity
Gain Therapeutics Inc (GANX) has a Long-term Investment Intensity of 4.6% as of March 2023. Long-term investments of $988.39K represent 4.6% of total assets of $21.32 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of Gain Therapeutics Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Gain Therapeutics Inc Long-term Investment Intensity (2022–2022)
This chart shows how Gain Therapeutics Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2022 to 2022. As of March 2023, the intensity stands at 4.6%, reflecting long-term investments of $988.39K against total assets of $21.32 Million USD. Also explore Gain Therapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Gain Therapeutics Inc (2022–2022)
The table below presents the year-by-year Long-term Investment Intensity for Gain Therapeutics Inc from 2022 to 2022, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Gain Therapeutics Inc worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 8.1% | $1.94 Million | $24.10 Million | — |